Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats

Food and Chemical Toxicology

Volumn 49, Issue 9, 2011, Pages 2013-2021

  Arjumand, Wani ^a   Seth, Amlesh ^b   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Caspase 3; Gammaglutamyl transpeptidase; Histopathology; Nephrotoxicity; NF B; TNF

Indexed keywords

CASPASE 3; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MOLECULAR MARKER; RUTOSIDE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; HISTOPATHOLOGY; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MALE; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; RENAL PROTECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CISPLATIN; INFLAMMATION; KIDNEY; MALE; NF-KAPPA B; RATS; RATS, WISTAR; RUTIN; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS NORVEGICUS;

EID: 79960843843     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.05.012     Document Type: Article

References (74)

1. Abraham E. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J. Infect. Dis. 2003, 187(Suppl. 2):S364-S369.
2. Afanas'ev I.B., Dorozhko A.I., Brodskii A.V., Kostyuk V.A., Potapovitch A.I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 1989, 38:1763-1769.
3. Ahmed M.M., Zaki N.I. Assessment the ameliorative effect of pomegranate and rutin on chloropyrifos-ethyl-induced oxidative stress in rats. Nat. Sci. 2009, 7:49-61.
4. Arany I., Safirstein R.L. Cisplatin nephrotoxicity 2003, Elsevier, pp. 460-464.
5. Berners-Price S.J., Kuchel P.W. Reaction of cis-and trans-[PtCl2(NH3)2] with reduced glutathione inside human red blood cells, studied by 1H and 15N-{1H} DEPT NMR. J. Inorg. Biochem. 1990, 38:327-345.
6. Bratton S.B., Cohen G.M. Apoptotic death sensor: an organelle's alter ego?. Trends Pharmacol. Sci. 2001, 22:306-315.
7. Camano S., Lazaro A., Moreno-Gordaliza E., Torres A.M., de Lucas C., Humanes B., Lazaro J.A., Milagros Gomez-Gomez M., Bosca L., Tejedor A. Cilastatin attenuates cisplatin-induced proximal tubular cell damage. J. Pharmacol. Exp. Ther. 2010, 334:419-429.
8. Camp E.R., Li J., Minnich D.J., Brank A., Moldawer L.L., MacKay S.L.D., Hochwald S.N. Inducible nuclear factor-[kappa] B activation contributes to chemotherapy resistance in gastric cancer1,* 1. J. Am. Coll. Surg. 2004, 199:249-258.
9. Carlberg I., Mannervik B. Glutathione reductase levels in rat brain. J. Biol. Chem. 1975, 250:90.
10. Cersosimo R.J. Hepatotoxicity associated with cisplatin chemotherapy. Ann. Pharmacother. 1993, 27:438-441.
11. Chang B., Nishikawa M., Sato E., Utsumi K., Inoue M. l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch. Biochem. Biophys. 2002, 405:55-64.
12. Chen S.S., Gong J., Liu F.T., Mohammed U. Naturally occurring polyphenolic antioxidants modulate IgE mediated mast cell activation. Immunology 2000, 100:471-480.
13. Cherry S.M., Hunt P.A., Hassold T.J. Cisplatin disrupts mammalian spermatogenesis, but does not affect recombination or chromosome segregation. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 2004, 564:115-128.
14. Caliborne A. 1985, 283-284. CRC Press.
15. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995, 9:899.
16. Crozier A., Burns J., Aziz A.A., Stewart A.J., Rabiasz H.S., Jenkins G.I., Edwards C.A., Lean M.E.J. Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. Biol. Res. 2000, 33:79-88.
17. Cummings B.S., Schnellmann R.G. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and-independent pathways. J. Pharmacol. Exp. Ther. 2002, 302:8.
18. Davis C.A., Nick H.S., Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J. Am. Soc. Nephrol. 2001, 12:2683-2690.
19. Faubel S., Lewis E.C., Reznikov L., Ljubanovic D., Hoke T.S., Somerset H., Oh D.J., Lu L., Klein C.L., Dinarello C.A., Edelstein C.L. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 2007, 322:8-15.
20. Francescato H.D.C., Costa R.S., Scavone C., Coimbra T.M. Parthenolide reduces cisplatin-induced renal damage. Toxicology 2007, 230:64-75.
21. Gao Z., Xu H., Huang K. Effects of rutin supplementation on antioxidant status and iron, copper, and zinc contents in mouse liver and brain. Biol. Trace Elem. Res. 2002, 88:271-279.
22. Ghosh S., May M.J., Kopp E.B. NF-{kappa} B and Rel proteins: evolutionarily conserved mediators of immune responses. Sci. STKE 1998, 16:225.
23. Gogvadze V., Orrenius S. Mitochondrial regulation of apoptotic cell death. Chem. Biol. Interact. 2006, 163:4-14.
24. Gonzales-Vitale J.C., Hayes D.M., Cvitkovic E., Sternberg S.S. The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 1977, 39:1362-1371.
25. Hanigan M.H., Gallagher B.C., Taylor P.T., Large M.K. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res. 1994, 54:5925-5929.
26. Hanigan M.H., Lykissa E.D., Townsend D.M., Ou C.N., Barrios R., Lieberman M.W. Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. Am. J. Pathol. 2001, 159:1889-1894.
27. Hare R.S. Endogenous creatinine in serum and urine. Proc. Soc. Exp. Biol. Med. 1950, 74:148-151.
28. Jo S.K., Cho W.Y., Sung S.A., Kim H.K., Won N.H. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 2005, 67:458-466.
29. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974, 11:151-169.
30. Kadikoylu G., Bolaman Z., Demir S., Balkaya M., Akalin N., Enli Y. The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum. Exp. Toxicol. 2004, 23:29-34.
31. Kaushal G.P., Kaushal V., Hong X., Shah S.V. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int. 2001, 60:1726-1736.
32. Kaushal G.P., Kaushal V., Hong X., Shah S.V. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int. 2001, 60:1726-1736.
33. Khan N., Sultana S. Chemomodulatory effect of Ficus racemosa extract against chemically induced renal carcinogenesis and oxidative damage response in Wistar rats. Life Sci. 2005, 77:1194-1210.
34. Kim Y.H., Kim Y.W., Oh Y.J., Back N.I., Chung S.A., Chung H.G., Jeong T.S., Choi M.S., Lee K.T. Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK 1 cells and rats. Biol. Pharm. Bull. 2006, 29:2436-2441.
35. Kornberg A. Methods in Enzymology 1955, Academic Press.
36. Kuhlmann M.K., Burkhardt G., Kohler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol. Dial. Transplant. 1997, 12:2478-2480.
37. Lin J.P., Yang J.S., Lu C.C., Chiang J.H., Wu C.L., Lin J.J., Lin H.L., Yang M.D., Liu K.C., Chiu T.H. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk. Res. 2009, 33:823-828.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
39. Lu L.H., Oh D.J., Dursun B., He Z., Hoke T.S., Faubel S., Edelstein C.L. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J. Pharmacol. Exp. Ther. 2008, 324:111.
40. Madias N.E., Harrington J.T. Platinum nephrotoxicity. Am. J. Med. 1978, 65:307-314.
41. Manach C., Morand C., Demigne C., Texier O., Régérat F., Rémésy C. Bioavailability of rutin and quercetin in rats. FEBS Lett. 1997, 409:12-16.
42. Masuda H., Tanaka T., Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem. Biophys. Res. Commun. 1994, 203:1175-1180.
43. Mohandas J., Marshall J.J., Duggin G.G., Horvath J.S., Tiller D.J. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney* 1: possible implications in analgesic nephropathy. Biochem. Pharmacol. 1984, 33:1801-1807.
44. MW K. Clinical Chemistry 1975, The Bobber Merrill Company Inc., USA.
45. Nagasawa T., Tabata N., Ito Y., Nishizawa N., Aiba Y., Kitts D.D. Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative. Mol. Cell. Biochem. 2003, 249:3-10.
46. Nijveldt R.J., van Nood E., van Hoorn D.E.C., Boelens P.G., van Norren K., van Leeuwen P.A.M. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001, 74:418-425.
47. Nishikawa M., Nagatomi H., Chang B.J., Sato E., Inoue M. Targeting superoxide dismutase to renal proximal tubule cells inhibits mitochondrial injury and renal dysfunction inuduced by cisplatin. Arch. Biochem. Biophys. 2001, 387:78-84.
48. Nowak G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J. Biol. Chem. 2002, 277:43377-43388.
49. O'Dwyer P., Stevenson J., Johnson S. Clinical status of cisplatin, carboplatin and other platinum-based antitumor drugs. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug 1999, 29-70. Wiley-VCH, Zurich. B. Lippert (Ed.).
50. Orfila C., Lepert J.C., Alric L., Carrera G., Beraud M., Pipy B. Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem. Cell Biol. 2005, 123:585-593.
51. Orlowski M., Meister A. Glutamyl cyclotransferase. Distribution, isozymic forms, and specificity. J. Biol. Chem. 1973, 248:2836-2844.
52. Pick E., Keisari Y. Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages - Induction by multiple nonphagocytic stimuli* 1. Cell. Immunol. 1981, 59:301-318.
53. Ramesh G., Reeves W.B. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 2002, 110:835-842.
54. Sadowitz P.D., Hubbard B.A., Dabrowiak J.C., Goodisman J., Tacka K.A., Aktas M.K., Cunningham M.J., Dubowy R.L., Souid A.K. Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. Drug Metab. Dispos. 2002, 30:183-190.
55. Sheikh-Hamad D., Timmins K., Jalali Z. Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment. J. Am. Soc. Nephrol. 1997, 8:1640.
56. Sheikh-Hamad D., Cacini W., Buckley A.R., Isaac J., Truong L.D., Tsao C.C., Kishore B.K. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch. Toxicol. 2004, 78:147-155.
57. Shino Y., Itoh Y., Kubota T., Yano T., Sendo T., Oishi R. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells. Free Radic. Biol. Med. 2003, 35:966-977.
58. Sorsa M., Hemminki K., Vainio H. Occupational exposure to anticancer drug-potential and real hazards. Mutat. Res. 1985, 154:135-149.
59. Stirpe F., della Corte E., With the technical assistance of, E.L. The regulation of rat liver xanthine oxidase. J. Biol. Chem. 1969, 244:3855-3863.
60. Sugihara K., Nakano S., Koda M., Tanaka K., Fukuishi N., Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jap. J. Pharmacol. 1987, 43:247-252.
61. Sun Z., Andersson R. NF-kappaB activation and inhibition: a review. Shock 2002, 18:99-106.
62. Townsend D.M., Hanigan M.H. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J. Pharmacol. Exp. Ther. 2002, 300:142-148.
63. Tugcu V., Ozbek E., Tasci A.I., Kemahli E., Somay A., Bas M., Karaca C., Altug T., Cekmen M.B., Ozdogan H.K. Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin. BJU Int 2006, 98:680-686.
64. Uivarosi V., Barbuceanu S.F., Aldea V., Arama C.C., Badea M., Olar R., Marinescu D. Synthesis, spectral and thermal studies of new rutin vanadyl complexes. Molecules 2010, 15:1578. (Basel, Switzerland).
65. Wang D., Lippard S.J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discovery 2005, 4:307-320.
66. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 1999, 79:143.
67. Wolfgang G.H.I., Dominick M.A., Walsh K., Hoeschele J.D., Pegg D.G. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male wistar rats. Toxicol. Sci. 1994, 22:73.
68. Wright J.R., Colby H.D., Miles P.R. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys. 1981, 206:296-304.
69. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J. Nutr. 2004, 134:489.
70. Yamaguchi K., Ishikawa T., Kondo Y., Fujisawa M. Cisplatin regulates sertoli cell expression of transferrin and interleukins. Mol. Cell. Endocrinol. 2008, 283:68-75.
71. Yao X., Panichpisal K., Kurtzman N., Nugent K. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 2007, 334:115.
72. Yilmaz H.R., Iraz M., Sogut S., Ozyurt H., Yildirim Z., Akyol O., Gergerlioglu S. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 2004, 50:287-290.
73. Zhan Y., van de Water B., Wang Y., Stevens J.L. The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells. Oncogene 1999, 18:6505-6512.
74. Zhou H., Miyaji T., Kato A., Fujigaki Y., Sano K., Hishida A. Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death. J. Lab. Clin. Med. 1999, 134:649-658.